Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Purchase |
2025-04-04 10:54 am |
Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner |
3,768,397 | $0.1046 | $394,174 | 20,401,602 (Direct) |
View |
| 2024-10-29 Purchase |
2024-11-05 12:42 pm |
Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner |
13,252,112 | $0 | $0 | 29,823,881 (Direct) |
View |
| 2023-09-11 Purchase |
2023-09-11 8:24 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
2,053,789 | $0.5112 | $1,049,897 | 12,502,868 (Indirect Direct) |
View |
| 2023-07-31 Purchase |
2023-08-25 7:33 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
880,195 | $0.5113 | $450,044 | 7,515,093 (Indirect Direct) |
View |
| 2023-01-04 Purchase |
2023-01-06 4:45 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
743,243 | $1.23 | $914,189 | 5,177,653 (Indirect Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 9:02 pm |
Eterna Therapeutics Inc. | ERNA | Cherington Charles Director 10% Owner |
261,756 | $3.28 | $858,560 | 1,079,977 (Direct) |
View |
| 2022-10-20 Purchase |
2022-10-24 4:03 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
15,007 | $1.5779 | $23,680 | 2,204,681 (Indirect Direct) |
View |
| 2022-10-14 Purchase |
2022-10-18 4:04 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
19,519 | $1.648 | $32,167 | 2,189,674 (Indirect Direct) |
View |
| 2022-10-13 Purchase |
2022-10-14 4:03 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
10,481 | $1.6589 | $17,387 | 2,170,155 (Indirect Direct) |
View |
| 2022-09-29 Purchase |
2022-09-30 4:04 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
17,900 | $1.8702 | $33,477 | 2,159,674 (Indirect Direct) |
View |
| 2022-09-27 Purchase |
2022-09-29 4:02 pm |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
12,000 | $1.6851 | $20,221 | 2,141,774 (Indirect Direct) |
View |
| 2021-06-16 Sale |
2021-06-21 6:00 pm |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director 10% Owner |
400,000 | $15.74 | $6,296,568 | 5,894,101 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-29 Conversion |
2024-11-05 12:42 pm |
N/A N/A |
Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner |
2,819,546 | $0.5 | 29,823,881 (Direct) |
View |
| 2024-10-29 Conversion |
2024-11-05 12:42 pm |
N/A 2025-09-24 |
Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner |
1,368,626 | $0 | 29,823,881 (Direct) |
View |
| 2023-12-14 Expired |
2023-12-20 10:05 am |
2023-07-14 2028-07-14 |
Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner |
2,831,204 | $0 | 8,957,180 (Direct) |
View |
Ownership |
2022-09-14 8:04 pm |
N/A N/A |
Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner |
0 | $0 | 2,129,774 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-03 8:01 pm |
N/A 2032-08-01 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director |
380,900 | $0 | 380,900 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 9:00 pm |
N/A 2031-12-07 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director |
67,000 | $0 | 5,961,285 (Direct) |
View |
| 2021-06-01 Other |
2021-12-10 9:00 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director |
92 | $0 | 5,961,285 (Direct) |
View |
Ownership |
2021-04-19 7:34 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director 10% Owner |
0 | $0 | 6,313,297 (Direct) |
View |